Viewing Study NCT06341205


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-03-09 @ 1:58 AM
Study NCT ID: NCT06341205
Status: RECRUITING
Last Update Posted: 2025-09-11
First Post: 2024-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
Sponsor: Centre Hospitalier Universitaire de Nice
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 22-APN-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators